[1] 中华医学会肝病学分会药物性肝病学组.药物性肝损伤诊治指南.临床肝胆病病杂志,2015,31:1752-1769.
[2] 中华医学会肝病学分会,中华医学会消化病学会,中华医学会感染病学分会.自身免疫性肝炎诊断和治疗共识( 2015) .肝脏,2015,20:969-982.
[3] Sebode M, Schulz L, Lohse AW. "Autoimmune(-Like)" Drug and herb induced liver injury: new insights into molecular pathogenesis. Int J Mol Sci, 2017,18:1954.
[4] Weiler-Normann C, Schramm C. Drug induced liver injury and its relationship to autoimmune hepatitis. J Hepatol, 2011, 55: 747-749.
[5] 苗琪,马雄.自身免疫性肝炎与药物性肝损伤:鉴别诊断和处理.中华肝脏病杂志, 2012年,20:327-329.
[6] Czaja AJ. Drug-induced autoimmune-like hepatitis. Dig Dis Sci,2011, 56:958-976.
[7] Björnsson E, Talwalkar J, Treeprasertsuk S, et al. Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology, 2010, 51:2040-2048.
[8] Watkins PB, Seeff LB. Drug-induced liver injury: summary of a single topic clinical research conference. Hepatology, 2006, 43:618-631.
[9] Fontana RJ, Seeff LB, Andrade RJ, et al. Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop. Hepatology, 2010, 52:730-742.
[10] Lucena MI, Kaplowitz L, Hallal H, et al. Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish registry. The dilemma of the relationship to autoimmune hepatitis. J Hepatol, 2011,55:70-77.
[11] Highball MA, Nikita S, Satire MR. Mechanisms of phenacetin toxicity in freshly isolated rat phagocytes and the protective of Maurine and / or Melanie.J Bio chem Col Toxic,2014,28:111-118.
[12] 李彩华, 金剑. 抗菌药物引起肝损伤的发病机制及临床特点. 医药导报,2016,35:75-78.
[13] Han D, Cara L, Win S ,et al. Rcirculation of drug-induced liver injury by signal introductions pathways: critical role foo Mondrian.Trends Pharmacologist Sci,2013,34:243-253.
[14] 许新, 季莉莎, 等. 药物性肝损伤发病机制的研究进展. 临床肝胆病杂志,2016,32:382-385.
[15] Chitchat MD, Haas DW, Minnesinger AA, et al. Drug transporter and metabolizing enzyme gene variants and alphanumerical-transcribe .inhibitor. Toxicity.Disinfectant,2006,43:779-782.
[16] Pessayre D,Mansoufi A,Berson A,et al.Mitochondrial involvement in drug-induced liver injury.Handb Exp Pharmacol,2010:311-365.
[17] 明雅南, 刘晓琳, 茅益民. 药物性肝损伤发病机制研究进展. 实用肝脏病杂志,2014,17:657-660.
[18] 梁德娇,梁列新,张法灿.自身免疫性肝炎的病因及发病机制研究进展.临床消化病杂志,2016,28:393-396.
[19] European association for the study of the liver.EASL clinical practice guidelines:autoimmune hepatitis.J Hepatol,2015,63:971-1004.
[20] Suzuki A, Brunt EM, Kleiner DE, et al. The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury. Hepatology, 2011, 54:931-939.
[21] Ju HY, Jang JY. The clinical features of drug-induced liver injury observed through liver biopsy: focus on relevancy to autoimmune hepatitis . Clin Mol Hepatol,2012,18;213-218.
[22] Lewis JH.Diagnosis:liver biopsy differentiates DILI from autoimmune hepatitis.Nat Rev Gastroenterol Hepatol,2011, 8:540-554.
[23] 王一,李燕妮,张洁,等.免疫性和药物性肝损伤临床鉴别的新进展,中华肝脏病杂志2017,25:717-720.
[24] 贺蕾艳,郭瑶雪,李春,等.药物性肝损伤生物标志物研究进展.药学学报,2015,50:959-965.
[25] 于乐成,何长伦,侯金林.药物诱导性肝损伤生物标志物研究进展. 实用肝脏病杂志,2014,17:564-568. |
